Federated Hermes, Inc. Scynexis Inc Transaction History
Federated Hermes, Inc.
- $43.9 Billion
- Q1 2025
A detailed history of Federated Hermes, Inc. transactions in Scynexis Inc stock. As of the latest transaction made, Federated Hermes, Inc. holds 2,895,000 shares of SCYX stock, worth $2.11 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,895,000
Previous 2,895,000
-0.0%
Holding current value
$2.11 Million
Previous $3.33 Million
17.39%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding SCYX
# of Institutions
46Shares Held
12.2MCall Options Held
0Put Options Held
2K-
Kingdon Capital Management, L.L.C. New York, NY2.24MShares$1.63 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.66MShares$1.21 Million0.0% of portfolio
-
Avidity Partners Management LP Dallas, TX1.23MShares$897,1040.26% of portfolio
-
Amh Equity LTD627KShares$457,7370.97% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC556KShares$405,5550.7% of portfolio
About SCYNEXIS INC
- Ticker SCYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 32,651,800
- Market Cap $23.8M
- Description
- SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...